Therapeutic Asset Ratings

141 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Rivaroxaban Stroke	China National Center for Cardiovascular Diseases	P4	BBB (72)
Tenecteplase Stroke	Assistance Publique - Hôpitaux de Paris	P4	BBB (72)
Acetylsalicylic Acid Stroke	China National Center for Cardiovascular Diseases	P4	BB (71)
Lipitor Stroke	Duan Chuanzhi	P4	BB (71)
Plavix Stroke	Shanghai CureGene Pharmaceutical Co., Ltd.	P4	BB (71)
Ticagrelor Stroke	Assistance Publique - Hôpitaux de Paris	P4	BB (71)
WARFARIN Stroke	China National Center for Cardiovascular Diseases	P4	BB (71)
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Stroke	Northern California Institute of Research and Education	P4	BB (70)
Edoxaban Stroke	Ewha Womans University Seoul Hospital	P4	BB (70)
Recombinant Human Plasminogen Activator Stroke	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P4	BB (70)
Xeomin® Stroke	Universiteit Antwerpen	P4	BB (70)
LIDOCAINE Stroke	Institut National de la Santé Et de la Recherche Médicale, France	P4	BB (67)
PROPOFOL Stroke	Johns Hopkins University	P4	BB (67)
SIMVASTATIN Stroke	Northern California Institute of Research and Education	P4	BB (67)
Cerebrolysin Stroke	Cardinal Stefan Wyszynski University	P4	BB (66)
Compound Edaravone Stroke	Second Affiliated Hospital, School of Medicine, Zhejiang University	P4	BB (66)
Dabigatran Stroke	Brigham and Women's Hospital	P4	BB (66)
Dipyridamole Stroke	The Second Hospital of Anhui Medical University	P4	BB (66)
Tirofiban Stroke	Weifang Medical University	P4	BB (66)
Apixaban Stroke	Columbia University	P4	BB (65)
METAMIZOLE Stroke	Region Örebro County	P4	BB (65)
Rosuvastatin Stroke	Assiut University	P4	BB (65)
Hydroxyurea Stroke	Vanderbilt University Medical Center	P4	BB (64)
LEVODOPA Stroke	University Hospital, Basel, Switzerland	P4	BB (64)
Arestin Stroke	Joyce Chen	P4	B (63)

Showing 1 to 25 of 141 assets

PreviousPage 1 of 6Next